AstraZeneca, RBS, Allianz: Business news in brief, Saturday 18 Feb
British pharmaceutical shares rise on success of breast cancer drug; bank set to announce further job cuts; Allianz plays down acquisition talks
British pharmaceutical shares rise on success of breast cancer drug; bank set to announce further job cuts; Allianz plays down acquisition talks
Damning report by MPs warns that doctors and patients are being ‘undermined’ on treatment options
FTSE 100 directors’ total remuneration up 14 per cent on share award deals
Sir Frank Chapman, the former boss of oil and gas company BG Group, is revealed as the richest pensioner in the FTSE 100 with a pot worth more than £22m when he stepped down.
Genetics, stem cells and consistent dividends can offset the problems of expiring patents
American companies are preparing to launch daring takeover bids for a host of Britain's biggest corporate names – including BAE Systems and AstraZeneca – thanks to the weakness of the pound against the dollar.
Police confirm drugs discovery two days before singer is due to be buried at Hollywood cemetery
After 52 weeks, The Independent's Share Challenge came to a close last weekend – with Colin McLean, our professional fund manager, easily beating both the school pupils from Leicester's Moat Community College and the group of hobby investors from Singleton Birch, the UK's largest lime producer. He receives £2,000, courtesy of our competition sponsors Abbey Sharedealing, and has said he plans to donate the money to the Teenage Cancer Trust.
Cabinet minister issues stark warning of carnage for private and public sectors as employers delay huge redundancies until the new year